Lupus Science and Medicine Podcast

By BMJ Group

The Lupus Science & Medicine® podcast is your premier source for the latest insights and developments in lupus and related diseases. Each episode features in-depth interviews with authors and lead... more

3.9

1414 ratings

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Lupus Science and Medicine Podcast:

How many episodes does Lupus Science and Medicine Podcast have?

The podcast currently has 61 episodes available.

Lupus Science and Medicine Podcast episodes:

August 07, 2023 Understanding Lupus: Exploring the Differences between Type 1 and Type 2 Symptoms
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Amrie Grammer and Dr. Peter Lipsky from AMPEL BioSolutions. Together they describe the molecular endotypes of Type 1 and Type 2 Systemic Lupus Erythematosus. This episode uncovers the distinct molecular profiles of these SLE types and paves the way for personalized treatment approaches based on these classifications.

Link to published paper: https://lupus.bmj.com/content/10/1/e000861
...more
21min
July 03, 2023 Unpacking Lupus Treatment: How Quickly Does Anifrolumab Start Working? Insights from TULIP Trials
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Ian Bruce, from the University of Manchester in the UK. Dr Bruce discusses the time to onset of clinical response to Anifrolumab in patients with Systemic Lupus Erythematosus. The episode delves into pooled data from two significant Phase III trials, TULIP-1 and TULIP-2, offering listeners a deep understanding of the effectiveness and timeline of Anifrolumab treatment.

Read the article: http://dx.doi.org/10.1136/lupus-2022-000761
...more
15min
May 24, 2023 Biomarker reduction indicates treatment response to Belimumab
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation between the decrease in urinary CD163 levels and the response to Belimumab treatment in Lupus Nephritis trials. The conversation provides important insights into the efficacy of this treatment option and potential biomarker use for personalized and precision medicine in the future.

Read the article: dx.doi.org/10.1136/lupus-2022-000763
...more
15min
May 18, 2023 Biomarker reduction indicates treatment response to Belimumab
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation between the decrease in urinary CD163 levels and the response to Belimumab treatment in Lupus Nephritis trials. The conversation provides important insights into the efficacy of this treatment option and potential biomarker use for personalized and precision medicine in the future.
Read the article: http://dx.doi.org/10.1136/lupus-2022-000763
...more
15min
August 02, 2022 Mesenchymal stromal cells: a potential new SLE treatment option?
Duane Peters from the Lupus Foundation of America interviews Dr Gary Gilkeson from the Medical University of South Carolina about a phase I trial into the use of mesenchymal stromal cells (MSC) in refractory lupus patients in the USA, following impressive results of clinical improvement resulting from this therapy in China.
The trial indicated that infusions of MSCs derived from the umbilical cord are safe and may be effective in treating mild to moderate systemic lupus erythematosus, with minimal adverse effects.
Access the article: http://dx.doi.org/10.1136/lupus-2022-000704
...more
18min
May 26, 2022 Using patient registries to estimate SLE incidence rate in the USA
Duane Peters from the Lupus Foundation of America interviews Dr Peter Izmirly from New York University and Dr Elizabeth Ferucci from the Alaska Native Tribal Health Consortium, both in the USA.
They discuss the establishment of a network of population-based lupus patient registries in the USA and how these have been used to estimate the incidence rate of systemic lupus erythematosus using standardised data stratified by sex, race and ethnicity.
Access the article: https://lupus.bmj.com/content/8/1/e000614
...more
17min
May 26, 2022 Defining remission in systemic lupus erythematosus
Duane Peters from the Lupus Foundation of America interviews Professor Ronald van Vollenhoven from the Amsterdam University Medical Centers in the Netherlands and Dr Cynthia Aranow from the Feinstein Institute for Medical Research in New York, USA.
They discuss the efforts of the DORIS international task force to agree on a single definition of remission in systemic lupus erythematosus, which they hope will ensure that clinicians, patients and researchers in the field are all working towards the same outcome.
Access the article: https://lupus.bmj.com/content/8/1/e000538
...more
20min
April 28, 2022 What’s the relationship between self-efficacy and quality of life in SLE patients?
Duane Peters from the Lupus Foundation of America talks to Dr Cristina Drenkard from Emory University and Dr Teresa Brady from Clarity Consulting and Communications, both based in Atlanta, USA.
They discuss their paper on the relationship between levels of self-efficacy and health behaviours and outcomes in black women with SLE. Their study specifically evaluated the associations between age, educational level and depression in SLE patients and the degree of pain and fatigue they experienced. These findings may help predict who might benefit most from self-efficacy-enhancing interventions to improve quality of life.
Access the article: https://lupus.bmj.com/content/9/1/e000566
...more
21min
April 06, 2022 Challenging but achievable: reaching Low Lupus Disease Activity State (LLDAS) in childhood-onset SLE
Duane Peters from the Lupus Foundation of America talks to Dr Sylvia Kamphuis and Dr Javad Wahadat from the Erasmus Medical Center in Rotterdam in the Netherlands about aiming for a Low Lupus Disease Activity State (LLDAS) in children with systemic lupus erythematosus (SLE). They outline the difference between LLDAS and clinical remission (CR), and discuss how LLDAS may be a more achievable target for patients than CR that nevertheless still brings significant clinical benefits in terms of decreasing damage accrual and improving health-related quality of life.
Access the paper here: https://lupus.bmj.com/content/8/1/e000571
...more
21min
February 24, 2022 Could a high fiber diet positively impact the gut microbiome of SLE patients?
Duane Peters from the Lupus Foundation of America interviews Professor Iryna Kulyk from Indiana University in the USA and Professor Martin Kriegel from the University of Münster in Germany and Yale University in the USA. They discuss their study, presented at the Lupus 21st Century conference in September 2021, on the influence of the consumption of resistant starch (a type of dietary fiber) on the composition of the gut microbiota of lupus patients.
Access the abstract here: https://lupus.bmj.com/content/8/Suppl_2/A63.2.abstract
...more
16min

FAQs about Lupus Science and Medicine Podcast:

How many episodes does Lupus Science and Medicine Podcast have?

The podcast currently has 61 episodes available.

More shows like Lupus Science and Medicine Podcast

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

501 Listeners

Medicine and Science from The BMJ by The BMJ

Medicine and Science from The BMJ

38 Listeners

BJSM Podcast by BMJ Group

BJSM Podcast

51 Listeners

DTB Podcast by BMJ Group

DTB Podcast

5 Listeners

Gut Podcast by BMJ Group

Gut Podcast

8 Listeners

Sharp Scratch by The BMJ

Sharp Scratch

5 Listeners

ADC Podcast by BMJ Group

ADC Podcast

3 Listeners

Thorax Podcast by BMJ Group

Thorax Podcast

2 Listeners

STI Podcast by BMJ Group

STI Podcast

4 Listeners

JNNP Podcast by BMJ Group

JNNP Podcast

9 Listeners

Heart Podcast by BMJ Group

Heart Podcast

38 Listeners

JNIS Podcast by BMJ Group

JNIS Podcast

14 Listeners

EBN Podcast by BMJ Group

EBN Podcast

1 Listeners

Practical Neurology Podcast by BMJ Group

Practical Neurology Podcast

52 Listeners

FG Podcast by BMJ Group

FG Podcast

0 Listeners

Medical Humanities Podcast by BMJ Group

Medical Humanities Podcast

6 Listeners

20/20 by ABC News

20/20

11,884 Listeners

ARD Podcast by BMJ Group

ARD Podcast

3 Listeners

Rheumnow Podcast by Dr. Cush

Rheumnow Podcast

123 Listeners

The Daily by The New York Times

The Daily

112,329 Listeners

RMD Open Podcast by BMJ Group

RMD Open Podcast

3 Listeners

BMJ Best Practice Podcast by BMJ Group

BMJ Best Practice Podcast

26 Listeners

Crime Junkie by audiochuck

Crime Junkie

368,454 Listeners

IJGC Podcast by BMJ Group

IJGC Podcast

24 Listeners

Dateline NBC by NBC News

Dateline NBC

47,964 Listeners

ACR on Air by American College of Rheumatology

ACR on Air

68 Listeners

Lupus: The Expert Series by Lupus Foundation of America

Lupus: The Expert Series

33 Listeners

Huberman Lab by Scicomm Media

Huberman Lab

29,196 Listeners

Butterfly Miracles - Living with Lupus and Beyond by Heather Moran by Heather Moran

Butterfly Miracles - Living with Lupus and Beyond by Heather Moran

4 Listeners

The Mel Robbins Podcast by Mel Robbins

The Mel Robbins Podcast

20,173 Listeners

The Lupus Academy by The Lupus Academy

The Lupus Academy

2 Listeners

Becoming Immune Confident by Kara Wada, MD

Becoming Immune Confident

45 Listeners

Lupus by Inception Point Ai

Lupus

2 Listeners

Medscape InDiscussion: Systemic Lupus Erythematosus by Medscape

Medscape InDiscussion: Systemic Lupus Erythematosus

0 Listeners